DEFERASIROX
| Brand name | JADENU |
|---|---|
| Active ingredient | DEFERASIROX |
| Strength | 90MG |
| Dosage form | TABLET |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | March 2015 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 9283209 | November 2034 | substance, product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.